278 related articles for article (PubMed ID: 18332182)
1. CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.
Petrie EJ; Clements CS; Lin J; Sullivan LC; Johnson D; Huyton T; Heroux A; Hoare HL; Beddoe T; Reid HH; Wilce MC; Brooks AG; Rossjohn J
J Exp Med; 2008 Mar; 205(3):725-35. PubMed ID: 18332182
[TBL] [Abstract][Full Text] [Related]
2. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
Malmberg KJ; Levitsky V; Norell H; de Matos CT; Carlsten M; Schedvins K; Rabbani H; Moretta A; Söderström K; Levitskaya J; Kiessling R
J Clin Invest; 2002 Nov; 110(10):1515-23. PubMed ID: 12438449
[TBL] [Abstract][Full Text] [Related]
4. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.
Vance RE; Jamieson AM; Raulet DH
J Exp Med; 1999 Dec; 190(12):1801-12. PubMed ID: 10601355
[TBL] [Abstract][Full Text] [Related]
5. Exclusion of lipid rafts and decreased mobility of CD94/NKG2A receptors at the inhibitory NK cell synapse.
Sanni TB; Masilamani M; Kabat J; Coligan JE; Borrego F
Mol Biol Cell; 2004 Jul; 15(7):3210-23. PubMed ID: 15133125
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen E contributes to protect tumor cells from lysis by natural killer cells.
Lo Monaco E; Tremante E; Cerboni C; Melucci E; Sibilio L; Zingoni A; Nicotra MR; Natali PG; Giacomini P
Neoplasia; 2011 Sep; 13(9):822-30. PubMed ID: 21969815
[TBL] [Abstract][Full Text] [Related]
7. HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.
Yokoyama WM
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4791-4. PubMed ID: 9560179
[No Abstract] [Full Text] [Related]
8. Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.
Li D; Brackenridge S; Walters LC; Swanson O; Harlos K; Rozbesky D; Cain DW; Wiehe K; Scearce RM; Barr M; Mu Z; Parks R; Quastel M; Edwards RJ; Wang Y; Rountree W; Saunders KO; Ferrari G; Borrow P; Jones EY; Alam SM; Azoitei ML; Gillespie GM; McMichael AJ; Haynes BF
Commun Biol; 2022 Mar; 5(1):271. PubMed ID: 35347236
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function.
Mbiribindi B; Pena JK; Arvedson MP; Moreno Romero C; McCarthy SR; Hatton OL; Esquivel CO; Martinez OM; Krams SM
Sci Rep; 2020 Nov; 10(1):19973. PubMed ID: 33203899
[TBL] [Abstract][Full Text] [Related]
10. The MHC-E peptide ligands for checkpoint CD94/NKG2A are governed by inflammatory signals, whereas LILRB1/2 receptors are peptide indifferent.
Middelburg J; Ghaffari S; Schoufour TAW; Sluijter M; Schaap G; Göynük B; Sala BM; Al-Tamimi L; Scheeren F; Franken KLMC; Akkermans JJLL; Cabukusta B; Joosten SA; Derksen I; Neefjes J; van der Burg SH; Achour A; Wijdeven RHM; Weidanz J; van Hall T
Cell Rep; 2023 Dec; 42(12):113516. PubMed ID: 38048225
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
[TBL] [Abstract][Full Text] [Related]
12. Effects of Peptide on NK cell-mediated MHC I recognition.
Cassidy SA; Cheent KS; Khakoo SI
Front Immunol; 2014; 5():133. PubMed ID: 24744756
[TBL] [Abstract][Full Text] [Related]
13. Endocytosis as a mechanism of regulating natural killer cell function: unique endocytic and trafficking pathway for CD94/NKG2A.
Peruzzi G; Masilamani M; Borrego F; Coligan JE
Immunol Res; 2009; 43(1-3):210-22. PubMed ID: 18979076
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific memory NK cell responses against HIV and influenza use the NKG2/HLA-E axis.
Jost S; Lucar O; Lee E; Yoder T; Kroll K; Sugawara S; Smith S; Jones R; Tweet G; Werner A; Tomezsko PJ; Dugan HL; Ghofrani J; Rascle P; Altfeld M; Müller-Trutwin M; Goepfert P; Reeves RK
Sci Immunol; 2023 Dec; 8(90):eadi3974. PubMed ID: 38064568
[TBL] [Abstract][Full Text] [Related]
15. NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer.
Salomé B; Sfakianos JP; Ranti D; Daza J; Bieber C; Charap A; Hammer C; Banchereau R; Farkas AM; Ruan DF; Izadmehr S; Geanon D; Kelly G; de Real RM; Lee B; Beaumont KG; Shroff S; Wang YA; Wang YC; Thin TH; Garcia-Barros M; Hegewisch-Solloa E; Mace EM; Wang L; O'Donnell T; Chowell D; Fernandez-Rodriguez R; Skobe M; Taylor N; Kim-Schulze S; Sebra RP; Palmer D; Clancy-Thompson E; Hammond S; Kamphorst AO; Malmberg KJ; Marcenaro E; Romero P; Brody R; Viard M; Yuki Y; Martin M; Carrington M; Mehrazin R; Wiklund P; Mellman I; Mariathasan S; Zhu J; Galsky MD; Bhardwaj N; Horowitz A
Cancer Cell; 2022 Sep; 40(9):1027-1043.e9. PubMed ID: 36099881
[TBL] [Abstract][Full Text] [Related]
16. Uterine NK Cells Ace an "A" in Education: NKG2A Sets Up Crucial Functions at the Maternal-Fetal Interface.
Colucci F
J Immunol; 2022 Oct; 209(8):1421-1425. PubMed ID: 36192118
[TBL] [Abstract][Full Text] [Related]
17. A novel system of polymorphic and diverse NK cell receptors in primates.
Averdam A; Petersen B; Rosner C; Neff J; Roos C; Eberle M; Aujard F; Münch C; Schempp W; Carrington M; Shiina T; Inoko H; Knaust F; Coggill P; Sehra H; Beck S; Abi-Rached L; Reinhardt R; Walter L
PLoS Genet; 2009 Oct; 5(10):e1000688. PubMed ID: 19834558
[TBL] [Abstract][Full Text] [Related]
18. Recognition of host Clr-b by the inhibitory NKR-P1B receptor provides a basis for missing-self recognition.
Balaji GR; Aguilar OA; Tanaka M; Shingu-Vazquez MA; Fu Z; Gully BS; Lanier LL; Carlyle JR; Rossjohn J; Berry R
Nat Commun; 2018 Nov; 9(1):4623. PubMed ID: 30397201
[TBL] [Abstract][Full Text] [Related]
19. The role of HLA-G in immunity and hematopoiesis.
Carosella ED; Gregori S; Rouas-Freiss N; LeMaoult J; Menier C; Favier B
Cell Mol Life Sci; 2011 Feb; 68(3):353-68. PubMed ID: 21116680
[TBL] [Abstract][Full Text] [Related]
20. HLA-dependent tumour development: a role for tumour associate macrophages?
Marchesi M; Andersson E; Villabona L; Seliger B; Lundqvist A; Kiessling R; Masucci GV
J Transl Med; 2013 Oct; 11():247. PubMed ID: 24093459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
